No QTc prolongation with CDK 4/6 inhibitor FCN-437c: results of a concentration-QTc analysis from a dedicated study in adult healthy subjects
Authors
- Lei Diao (ORCID: https://orcid.org/0000-0002-0979-8827)
- Fangfang Wang (ORCID: https://orcid.org/0000-0002-5441-4490)
- Xiaoran Yang (ORCID: https://orcid.org/0000-0001-5451-4945)
- Ling Tian
- Lize Li
- Xiaoye Niu
- Haiyan Li (ORCID: https://orcid.org/0009-0003-1147-8085)
- Lin Zhao (ORCID: https://orcid.org/0000-0003-2253-4081)
- Yi Sun (ORCID: https://orcid.org/0000-0001-8169-8612)
Institutions
- Peking University (CN)
- Fosun Pharma (China) (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.3389/fphar.2024.1433663
- Citations
- 1
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.42